Effect of folate-targeted nanoparticle size on their rates of penetration into solid tumors

ACS Nano

Volumn 7, Issue 10, 2013, Pages 8573-8582

  Vlashi, Erina ^a,c   Kelderhouse, Lindsay E ^a   Sturgis, Jennifer E ^b   Low, Philip S ^a  

^a PURDUE UNIVERSITY   (United States)

^b PURDUE UNIVERSITY   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

binding site barrier; folate receptor; intravital multiphoton microscopy; nanomedicines size; tumor accumulation

Indexed keywords

FOLATE RECEPTOR; MULTI-PHOTON MICROSCOPY; NANOMEDICINES; NANOPARTICLE SIZES; POLYETHYLENE GLYCOL (PEG); RATES-OF-PENETRATION; TUMOR ACCUMULATION; TUMOR PENETRATION;

BINDING SITES; DISEASE CONTROL; DISEASES; DRUG DELIVERY; LIGANDS; MOLECULAR BIOLOGY; OPTIMIZATION; POLYETHYLENE GLYCOLS;

TUMORS;

FLUORESCEIN; FOLIC ACID; MACROGOL DERIVATIVE; NANOPARTICLE;

ARTICLE; CHEMISTRY; HUMAN; METABOLISM; MOLECULAR WEIGHT; NEOPLASM; PARTICLE SIZE; TUMOR CELL LINE;

CELL LINE, TUMOR; FLUORESCEIN; FOLIC ACID; HUMANS; MOLECULAR WEIGHT; NANOPARTICLES; NEOPLASMS; PARTICLE SIZE; POLYETHYLENE GLYCOLS;

EID: 84886991790     PISSN: 19360851     EISSN: 1936086X     Source Type: Journal    
DOI: 10.1021/nn402644g     Document Type: Article

References (48)

1. Dreher, M. R.; Liu, W.; Michelich, C. R.; Dewhirst, M. W.; Yuan, F.; Chilkoti, A. Tumor Vascular Permeability, Accumulation, and Penetration of Macromolecular Drug Carriers J. Natl. Cancer Inst. 2006, 98, 335-344
2. Torchilin, V. P. Recent Advances with Liposomes as Pharmaceutical Carriers Nat. Rev. Drug Discovery 2005, 4, 145-160
3. Kataoka, K.; Harada, A.; Nagasaki, Y. Block Copolymer Micelles for Drug Delivery: Design, Characterization and Biological Significance Adv. Drug Delivery Rev. 2001, 47, 113-131
4. Senter, P. D.; Springer, C. J. Selective Activation of Anticancer Prodrugs by Monoclonal Antibody-Enzyme Conjugates Adv. Drug Delivery Rev. 2001, 53, 247-264
5. Patri, A. K.; Majoros, I. J.; Baker, J. P. Dendritic Polymer Macromolecular Carriers for Drug Delivery Curr. Opin. Chem. Biol. 2002, 6, 466-471
6. Jones, M. C.; Leroux, J. C. Polymeric Micelles-A New Generation of Colloidal Drug Carriers Eur. J. Pharm. Biopharm. 1999, 48, 101-111
7. Panyam, J.; Labhasetwar, V. Biodegradable Nanoparticles for Drug and Gene Delivery to Cells and Tissue Adv. Drug Delivery Rev. 2003, 55, 329-347
8. Muller, R. H.; Mader, K.; Gohla, S. Solid Lipid Nanoparticles (SLN) for Controlled Drug Delivery-A Review of the State of the Art Eur. J. Pharm. Biopharm. 2000, 50, 161-177
9. De Jong, W. H.; Borm, P. J. A. Drug Delivery and Nanoparticles: Applications and Hazards Int. J. Nanomed. 2008, 3, 133-149
10. Wang, A. Z.; Langer, R.; Farokhzad, O. C. Nanoparticle Delivery of Cancer Drugs Annu. Rev. Med. 2012, 63, 185-198
11. Matsumura, Y.; Maeda, H. A New Concept for Macromolecular Therapeutics in Cancer Chemotherapy: Mechanism of Tumoritropic Accumulation of Proteins and the Antitumor Agent Smancs Cancer Res. 1986, 46, 6387-6392
12. Maeda, H.; Matsumura, Y. Tumoritropic and Lymphotropic Principles of Macromolecular Drugs Crit. Rev. Ther. Drug Carrier Syst. 1989, 6, 193-210
13. Maeda, H.; Seymour, L. W.; Miyamoto, Y. Conjugates of Anticancer Agents and Polymers: Advantages of Macromolecular Therapeutics in Vivo Bioconjugate Chem. 1992, 3, 351-362
14. Masubuchi, N. Pharmacokinetics of DE-310, a Novel Macromolecular Carrier System for the Camptothecin Analog DX-8951f, in Tumor-Bearing Mice Pharmazie 2004, 59, 374-377
15. Mori, A.; Klibanov, A. L.; Torchilin, V. P.; Huang, L. Influence of the Steric Barrier Activity of Amphipathic Poly(ethyleneglycol) and Ganglioside GM1 on the Circulation Time of Liposomes and on the Target Binding of Immunoliposomes in Vivo FEBS Lett. 1991, 284, 263-266
16. Kaneda, Y.; Tsutsumi, Y.; Yoshioka, Y.; Kamada, H.; Yamamoto, Y.; Kodaira, H.; Tsunoda, S.; Okamoto, T.; Mukai, Y.; Shibata, H. et al. The Use of PVP as a Polymeric Carrier to Improve the Plasma Half-Life of Drugs Biomaterials 2004, 25, 3259-3266
17. Dvorak, H. F.; Nagy, J. A.; Dvorak, J. T.; Dvorak, A. M. Identification and Characterization of the Blood Vessels of Solid Tumors that are Leaky to Circulating Macromolecules Am. J. Pathol. 1988, 133, 95-109
18. Jain, R. K.; Baxter, L. T. Mechanisms of Heterogeneous Distribution of Monoclonal Antibodies and Other Macromolecules in Tumors: Significance of Elevated Interstitial Pressure Cancer Res. 1988, 48, 7022-7032
19. Jang, S. H.; Wientjes, M. G.; Lu, D.; Au, J. L-S. Drug Delivery and Transport to Solid Tumors Pharm. Res. 2003, 20, 1337-1350
20. Wang, J.; Lu, Z.; Gao, Y.; Wientjes, M. G.; Au, J. L-S. Improving Delivery and Efficacy of Nanomedicines in Solid Tumors Nanomedicine 2011, 6, 1605-1620
21. Ross, J. S.; Schenkein, D, P.; Pietrusko, R.; Rolfe, M.; Linette, G. P.; Stec, J.; Stagliano, N. E.; Ginsburg, G. S.; Symmans, W. F.; Pusztai, L. et al. Targeted Therapies for Cancer 2004 Am. J. Clin. Pathol. 2004, 122, 598-609
22. Allen, T. M. Ligand-Targeted Therapeutics in Anticancer Therapy Nat. Rev. Cancer 2002, 2, 750-763
23. Singh, R.; Lillard, J. W., Jr. Nanoparticle-Based Targeted Drug Delivery Exp. Mol. Pathol. 2009, 86, 215-223
24. Ganta, S.; Devalapally, H.; Shahiwala, A.; Amiji, M. A Review of Stimuli-Responsive Nanocarriers for Drug and Gene Delivery J. Controlled Release 2008, 126, 187-204
25. Cheng, Z.; Zaki, A. A.; Hui, J. Z.; Muzykantov, V. R.; Tsourkas, A. Multifunctional Nanoparticles: Cost versus Benefit of Adding Targeting and Imaging Capabilities Science 2012, 338, 903-910
26. Gu, F. X.; Karnik, R.; Wang, A. Z.; Alexis, F.; Levy-Nissenbaum, E.; Hong, S.; Langer, R. S.; Farokhzad, O. C. Targeted Nanoparticles for Cancer Therapy Nanotoday 2007, 2, 14-21
27. Gupta, Y.; Jain, A.; Jain, P.; Jain, S. K. Design and Development of Folate Appended Liposomes for Enhanced Delivery of 5-fu to Tumor Cells J. Drug Targeting 2007, 15, 231-240
28. Stevens, P. J.; Sekido, M.; Lee, R. J. A Folate Receptor-Targeted Lipid Nanoparticle Formulation for a Lipophilic Paclitaxel Prodrug Pharm. Res. 2004, 21, 2153-2157
29. Pan, X. Q.; Wang, H.; Lee, R. J. Antitumor Activity of Folate Receptor Targeted Liposomal Doxorubicin in a KB Oral Carcinoma Murine Xenograft Model Pharm. Res. 2003, 20, 417-422
30. Ohguchi, Y.; Kawano, K.; Hattori, Y.; Maitani, Y. Selective Delivery of Folate-PEG-Linked, Nanoemulsion-Loaded Aclacinomycin A to KB Nasopharyngeal Cells and Xenograft: Effect of Chain Length and Amount of Folate-PEG Linker J. Drug Targeting 2008, 16, 660-667
31. Shiokawa, T.; Hattori, Y.; Kawano, K.; Ohguchi, Y.; Kawakami, H.; Toma, K.; Maitani, Y. Effect of Polyethylene Glycol Linker Chain Length of Folate-Linked Microemulsions Loading Aclacinomycin A on Targeting Ability and Antitumor Effect in Vitro and in Vivo Clin. Cancer Res. 2005, 11, 2018-2025
32. Fujimori, K.; Covell, D. G.; Fletcher, J. E.; Weinstein, J. N. A Modeling Analysis of Monoclonal Antibody Percolation Through Tumors: a Binding-Site Barrier J. Nucl. Med. 1990, 31, 1191-1198
33. Juweid, M.; Neumann, R.; Paik, C.; Perez-Bacete, M. J.; Sato, J.; van Osdol, W.; Weinstein, J. N. Micropharmacology of Monoclonal Antibodies in Solid Tumors: Direct Experimental Evidence for a Binding Site Barrier Cancer Res. 1992, 52, 5144-5153
34. Saga, T.; Neumann, R. D.; Heya, T.; Sato, J.; Kinuya, S.; Le, N.; Paik, C. H.; Weinstein, J. N. Targeting Cancer Micrometastases with Monoclonal Antibodies: A Binding-Site Barrier Proc. Natl. Acad. Sci. U. S. A. 1995, 92, 8999-9003
35. Graff, C. P.; Wittrup, K. D. Theoretical Analysis of Antibody Targeting of Tumor Spheroids: Importance of Dosage for Penetration, and Affinity for Retention Cancer Res. 2003, 63, 1288-1296
36. Vlashi, E.; Sturgis, J. E.; Thomas, M.; Low, P. S. Real Time, Noninvasive Imaging and Quantitation of the Accumulation of Ligand-Targeted Drugs into Receptor-Expressing Solid Tumors Mol. Pharmaceutics 2009, 6, 1868-1875
37. Weitman, S. D.; Lark, R. H.; Coney, L. R.; Fort, D. W.; Frasca, V.; Zurawski, V. R., Jr.; Kamen, B. A. Distribution of the Folate Receptor GP38 in Normal and Malignant Cell Lines and Tissues Cancer Res. 1992, 52, 3396-3401
38. Ross, J. F.; Chaudhuri, P. K.; Ratnam, M. Differential Regulation of Folate Receptor Isoforms in Normal and Malignant Tissues in Vivo and in Established Cell Lines. Physiologic and Clinical Implications Cancer 1994, 73, 2432-2443
39. Parker, N.; Turk, M. J.; Westrick, E.; Lewis, J. D.; Low, P S.; Leamon, C. P. Folate Receptor Expression in Carcinomas and Normal Tissues Determined by a Quantitative Radioligand Binding Assay Anal. Biochem. 2005, 338, 284-293
40. Luo, J.; Smith, M. D.; Lantrip, D. A.; Wang, S.; Fuchs, P. L. Efficient Syntheses of Pyrofolic Acid and Pteroyl Azide, Reagents for the Production of Carboxyl-Differentiated Derivatives of Folic Acid J. Am. Chem. Soc. 1997, 119, 10004-10013
41. Turek, J. J.; Leamon, C. P.; Low, P. S. Endocytosis of Folate-Protein Conjugates: Ultrastructural Localization in KB Cells J. Cell Sci. 1993, 106, 423-430
42. Fee, C. J.; Van Alstine, J. M. Prediction of the Viscosity Radius and the Size Exclusion Chromatography Behavior of PEGylated Proteins Bioconjugate Chem. 2004, 15, 1304-1313
43. Choi, C. H. J.; Zuckerman, J. E.; Webster, P.; Davis, M. E. Targeting Kidney Mesangium by Nanoparticles of Defined Size Proc. Natl. Acad. Sci. U. S. A. 2011, 108, 6656-6661
44. Hak, S.; Reitan, N. K.; Haraldseth, O.; de Lange Davies, C. Intravital Microscopy in Window Chambers: A Unique Tool to Study Tumor Angiogenesis and Delivery of Nanoparticles Angiogenesis 2010, 13, 113-130
45. Jain, R. K. Delivery of Molecular and Cellular Medicine to Solid Tumors Adv. Drug Delivery Rev. 2001, 46, 149-168
46. van Osdol, W.; Fujimori, K.; Weinstein, J. N. An Analysis of Monoclonal Antibody Distribution in Microscopic Tumor Nodules: Consequences of a "Binding Site Barrier" Cancer Res. 1991, 51, 4776-4784
47. Weinstein, J. N.; van Osdol, W. Early Intervention in Cancer Using Monoclonal Antibodies and Other Biological Ligands: Micropharmacology and the "Binding Site Barrier" Cancer Res. 1992, 52, 2747s-2751s
48. Schuff, M. M.; Vlashi, E.; Low, P. S.; Nauman, E. A. Quantitative evaluation of receptor mediated targeting of solutes in cancerous tissue using a microvascular mixture theory model. J. Nanotechnol. Eng. Med., manuscript submitted.